Integrin α2 Level is a Critical Determinant for Mesenchymal to Endothelial Phenotype Transition of Trabecular Meshwork Cells
- 10 May 2026
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (7) , 828-837
Abstract
Glaucoma, a progressive visual field loss that eventually leads to blindness, is a problem worldwide. Current treatments for glaucoma progression reduce only intraocular pressure (IOP); the mechani...Keywords
Funding Information
- JSPS KAKENHI (JP23K09011)
This publication has 30 references indexed in Scilit:
- Role of integrin α2 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cellsToxicological Research, 2022
- Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degenerationProgress in Retinal and Eye Research, 2021
- Glaucoma in Adults—Screening, Diagnosis, and ManagementJAMA, 2021
- Plasticity of cancer cell invasion: Patterns and mechanismsTranslational Oncology, 2021
- MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2Tumor Biology, 2015
- Epithelial mesenchymal transition-like phenomenon in trabecular meshwork cellsExperimental Eye Research, 2014
- The role of TGF-β in the pathogenesis of primary open-angle glaucomaCell and tissue research, 2011
- Extracellular matrix in the trabecular meshworkExperimental Eye Research, 2008
- The effect of TGF-β2 on human trabecular meshwork extracellular proteolytic systemExperimental Eye Research, 2003
- Aqueous Humor in Glaucomatous Eyes Contains an Increased Level of TGF-β2Experimental Eye Research, 1994